172 related articles for article (PubMed ID: 10976413)
1. The prognostic value of age and follicle-stimulating hormone levels in women over forty years of age undergoing in vitro fertilization.
Watt AH; Legedza AT; Ginsburg ES; Barbieri RL; Clarke RN; Hornstein MD
J Assist Reprod Genet; 2000 May; 17(5):264-8. PubMed ID: 10976413
[TBL] [Abstract][Full Text] [Related]
2. Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in women younger than 40 years of age.
Yanushpolsky EH; Hurwitz S; Tikh E; Racowsky C
Fertil Steril; 2003 Jul; 80(1):111-5. PubMed ID: 12849811
[TBL] [Abstract][Full Text] [Related]
3. Comparison of basal and clomiphene citrate induced FSH and inhibin B, ovarian volume and antral follicle counts as ovarian reserve tests and predictors of poor ovarian response in IVF.
Erdem M; Erdem A; Gursoy R; Biberoglu K
J Assist Reprod Genet; 2004 Feb; 21(2):37-45. PubMed ID: 15186020
[TBL] [Abstract][Full Text] [Related]
4. Predictive power of clomiphene citrate challenge test for failure of in vitro fertilization treatment.
Csemiczky G; Harlin J; Fried G
Acta Obstet Gynecol Scand; 2002 Oct; 81(10):954-61. PubMed ID: 12366487
[TBL] [Abstract][Full Text] [Related]
5. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening.
Jain T; Soules MR; Collins JA
Fertil Steril; 2004 Jul; 82(1):180-5. PubMed ID: 15237009
[TBL] [Abstract][Full Text] [Related]
6. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve.
Hendriks DJ; Broekmans FJ; Bancsi LF; de Jong FH; Looman CW; Te Velde ER
Hum Reprod; 2005 Jan; 20(1):163-9. PubMed ID: 15471926
[TBL] [Abstract][Full Text] [Related]
7. Obstetric implications for and identification of women with a normal clomiphene citrate challenge test result who have a poor response to gonadotropins.
Hofmann GE; Sosnowski J; Khoury J; Kearns L; Thie J
Fertil Steril; 2004 Oct; 82(4):908-12. PubMed ID: 15482767
[TBL] [Abstract][Full Text] [Related]
8. Useful predictors of ovarian stimulation response in women undergoing in vitro fertilization.
van der Stege JG; van der Linden PJ
Gynecol Obstet Invest; 2001; 52(1):43-6. PubMed ID: 11549863
[TBL] [Abstract][Full Text] [Related]
9. Establishing institutional critical values of follicle-stimulating hormone levels to predict in vitro fertilization success.
Joiner LL; Robinson RD; Bates W; Propst AM
Mil Med; 2007 Feb; 172(2):202-4. PubMed ID: 17357778
[TBL] [Abstract][Full Text] [Related]
10. High live birth rate in the subsequent IVF cycle after first-cycle poor response among women with mean age 35 and normal FSH.
Moolenaar LM; Mohiuddin S; Munro Davie M; Merrilees MA; Broekmans FJ; Mol BW; Johnson NP
Reprod Biomed Online; 2013 Oct; 27(4):362-6. PubMed ID: 23953583
[TBL] [Abstract][Full Text] [Related]
11. Basal follicle stimulating hormone level correlated to age is a good prognostic criterion for the outcome of intracytoplasmic sperm microinjection.
Kdous M; Merdassi G; Zhioua F; Elloumi H; Kacem K; Zhioua A
Tunis Med; 2016 Mar; 94(3):181-5. PubMed ID: 27575500
[TBL] [Abstract][Full Text] [Related]
12. Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment.
Ng EH; Chan CC; Tang OS; Ho PC
Hum Reprod; 2005 Jun; 20(6):1647-54. PubMed ID: 15734749
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of some ovarian reserve tests in poor responders.
Vladimirov IK; Tacheva DM; Kalinov KB; Ivanova AV; Blagoeva VD
Arch Gynecol Obstet; 2005 Jun; 272(1):74-9. PubMed ID: 15660265
[TBL] [Abstract][Full Text] [Related]
14. Intercycle variability of ovarian reserve tests: results of a prospective randomized study.
Kwee J; Schats R; McDonnell J; Lambalk CB; Schoemaker J
Hum Reprod; 2004 Mar; 19(3):590-5. PubMed ID: 14998957
[TBL] [Abstract][Full Text] [Related]
15. Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome.
Fábregues F; Balasch J; Creus M; Carmona F; Puerto B; Quintó L; Casamitjana R; Vanrell JA
J Assist Reprod Genet; 2000 Jan; 17(1):13-9. PubMed ID: 10754778
[TBL] [Abstract][Full Text] [Related]
16. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle-stimulating hormone levels.
Tanbo T; Dale PO; Lunde O; Norman N; Abyholm T
Fertil Steril; 1992 Apr; 57(4):819-24. PubMed ID: 1555694
[TBL] [Abstract][Full Text] [Related]
17. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve.
Abdalla H; Thum MY
Hum Reprod; 2004 Apr; 19(4):893-8. PubMed ID: 15016786
[TBL] [Abstract][Full Text] [Related]
18. [FSH and IVF management: the best and worst case scenarios].
Aubriot FX; Chapron C
Gynecol Obstet Fertil; 2008 Jun; 36(6):636-40. PubMed ID: 18538623
[TBL] [Abstract][Full Text] [Related]
19. Examining the relationship between ovarian reserve, as measured by basal FSH levels, and the risk of poor obstetric outcome in singleton IVF gestations.
Calhoun KC; Fritz MA; Steiner AZ
Hum Reprod; 2011 Dec; 26(12):3424-30. PubMed ID: 21930533
[TBL] [Abstract][Full Text] [Related]
20. Luteal phase oestradiol and progesterone levels are stronger predictors than follicular phase follicle stimulating hormone for the outcome of in-vitro fertilization treatment in women with tubal infertility.
Csemiczky G; Wramsby H; Landgren BM
Hum Reprod; 1996 Nov; 11(11):2396-9. PubMed ID: 8981118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
